NANOEX
LIVE

Serial Number

99259207

Owner

Kaigene, Inc.

Attorney

Devon E. White

Filing Date

Jun 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NANOEX Trademark

Serial Number: 99259207

NANOEX is a trademark filed by Kaigene, Inc. on June 30, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Kaigene, Inc. (4 trademarks)

9808 Medical Center Dr. Suite #430
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

June 30, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical and therapeutic preparations, namely, a drug formulation using protein degradation for use in treating immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Biochemical preparations for medical use for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Proteins, protein fragments, and protein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseases, particularly autoimmune diseases

Chemical preparations for scientific purposes; Molecules for use in industry, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for use in science, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for molecular biology, other than for medical or veterinary use, namely, protein-modulating molecules for use in the pharmaceutical industry

Filing History

ASSIGNED TO EXAMINER
May 26, 2026 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 13, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 13, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 18, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 30, 2025 MAFR
NEW APPLICATION ENTERED
Jun 30, 2025 NWAP